MedTrace Logo

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

NCT00752141 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2011-09-23

No results posted yet for this study

Summary

The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.

Conditions

  • Healthy Volunteers

Interventions

DRUG

oxybutynin chloride immediate-release

capsule containing oxybutynin chloride immediate-release 5 mg tablet administered three times daily, and placebo gel administered once daily

DRUG

oxybutynin chloride topical gel

oxybutynin chloride topical gel applied once daily, and capsule containing placebo tablet administered three times daily

OTHER

placebo

capsule containing placebo tablet administered three times daily, and placebo gel administered once daily

Sponsors & Collaborators

  • Watson Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00752141 on ClinicalTrials.gov